Rare Disorders NZ has made a submission on the proposed guidelines on pre-implantation genetic testing for cases involving specialist disagreement.

RDNZ strongly recommends that the Advisory Committee on Assisted Reproductive Technology (ACART) ensure meaningful and ongoing consumer involvement, including representation from people living with rare disorders and their whānau, across any review process.

This aligns with Priority 4 of the Ministry of Health’s 2024 Aotearoa New Zealand Rare Disorders Strategy, "Giving voice to people and their whānau living with rare disorders", which recognises the importance of ensuring that lived-experience perspectives are reflected across the health system.

Read our full submission here.

Our Collective

Rare Disorders NZ is the collective voice of all people living with a rare disorder and their whānau. Our rare collective is made up of more than 150 disorder-specific support groups.

Our work is informed by the issues important to our collective. We work together to improve healthcare and wellbeing for everyone living with a rare health condition in New Zealand.

Learn more